Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 50003111
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467096(CHEMBL4278817)
Affinity DataIC50: 2nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467103(CHEMBL4289492)
Affinity DataIC50: 2nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50111384(CHEMBL3604794)
Affinity DataIC50: 4nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50111385(CHEMBL3604793)
Affinity DataIC50: 5nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50111372(CHEMBL3604771)
Affinity DataIC50: 20nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467099(CHEMBL4284142)
Affinity DataIC50: 38nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467096(CHEMBL4278817)
Affinity DataIC50: 50nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 54nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 120nMAssay Description:Inhibition of FLT3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase beta-1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 120nMAssay Description:Inhibition of RPS6KB1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50111384(CHEMBL3604794)
Affinity DataIC50: 210nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467103(CHEMBL4289492)
Affinity DataIC50: 232nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467101(CHEMBL4280695)
Affinity DataIC50: 240nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50111385(CHEMBL3604793)
Affinity DataIC50: 340nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467100(CHEMBL4276872)
Affinity DataIC50: 500nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467095(CHEMBL4277304)
Affinity DataIC50: 800nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467104(CHEMBL4288604)
Affinity DataIC50: 810nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of JAK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of JAK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of FGFR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of RET (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase receptor UFO(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of AXL (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467097(CHEMBL4292020)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of KDR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467102(CHEMBL4287512)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467098(CHEMBL4285259)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of RSK2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467101(CHEMBL4280695)
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50111372(CHEMBL3604771)
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467099(CHEMBL4284142)
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467104(CHEMBL4288604)
Affinity DataIC50: 7.20E+3nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467095(CHEMBL4277304)
Affinity DataIC50: 1.81E+4nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467100(CHEMBL4276872)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467102(CHEMBL4287512)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50467098(CHEMBL4285259)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of RSK2 (unknown origin) assessed as reduction in YB1 transmembrane phosphorylationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed